Wells Fargo’s Nuvectis Pharma NVCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49.7K | Buy |
+6,653
| New | +$49.7K | ﹤0.01% | 5087 |
|
|
2024
Q2 | – | Sell |
-2,200
| Closed | -$18K | – | 6824 |
|
|
2024
Q1 | $18K | Buy |
2,200
+298
| +16% | +$2.44K | ﹤0.01% | 5218 |
|
|
2023
Q4 | $15.9K | Buy |
1,902
+437
| +30% | +$3.65K | ﹤0.01% | 5282 |
|
|
2023
Q3 | $18.9K | Sell |
1,465
-1,380
| -49% | -$17.8K | ﹤0.01% | 5258 |
|
|
2023
Q2 | $45.4K | Buy |
2,845
+2,820
| +11,280% | +$45K | ﹤0.01% | 5175 |
|
|
2023
Q1 | $328 | Hold |
25
| – | – | ﹤0.01% | 6318 |
|
|
2022
Q4 | $188 | Buy |
25
+1
| +4% | +$8 | ﹤0.01% | 6306 |
|
|
2022
Q3 | $0 | Buy |
24
+3
| +14% | – | ﹤0.01% | 6808 |
|
|
2022
Q2 | $0 | Buy |
21
+1
| +5% | – | ﹤0.01% | 6961 |
|
|
2022
Q1 | $0 | Buy |
+20
| New | – | ﹤0.01% | 7056 |
|